Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00385827
Status:
TERMINATED
Last Update Posted:
2014-08-20
First Post:
2006-10-06
Brief Title:
A Safety and Efficacy Study of Siltuximab CNTO 328 in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer HRPC
Sponsor:
Centocor Inc
Organization:
Centocor Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-06
First Submit QC Date:
October 6 2006
Study First Post Date:
2006-10-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2014-06-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2013-01-31
Disp First Submit QC Date:
January 31 2013
Disp First Post Date:
2013-02-04
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-08-18
Last Update Post Date:
2014-08-20
Last Update Post Date Type:
ESTIMATED